STML - Stemline Therapeutics Inc. (STML) CEO Ivan Bergstein on Q4 2019 Results - Earnings Call Transcript
Stemline Therapeutics, Inc. (STML)
Q4 2019 Results Earnings Conference Call
March 16, 2020, 08:00 AM ET
Company Participants
Kenneth Hoberman - COO
Ivan Bergstein - Founder, President, CEO & Chairman
David Gionco - Senior VP of Finance & CAO
Robert Francomano - Chief Commercial Officer
Conference Call Participants
Jessica Fye - JPMorgan
Boris Peaker - Cowen
Matt Kaplan - Ladenburg Thalmann
Alethia Young - Cantor Fitzgerald
Joe Catanzaro - Piper Sandler
Yi Chen - H.C. Wainwright
Presentation
Operator
Good day. And welcome to the Stemline Earnings Conference Call. Today's conference is being recorded.
At this